Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1725430
Sentiment: neutral
Topics: disclosure, financials, regulatory
TL;DR
Intelligent Bio Solutions filed an 8-K on Jan 29, 2025, with Reg FD disclosures and financials.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on January 29, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal executive offices in New York, NY.
Why It Matters
This filing indicates that Intelligent Bio Solutions Inc. is providing updated disclosures and financial information to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically contains disclosures and exhibits without immediate material financial impact.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- January 29, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What was Intelligent Bio Solutions Inc. formerly known as?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
In which state is Intelligent Bio Solutions Inc. incorporated?
Intelligent Bio Solutions Inc. is incorporated in Delaware.
What is the address of the principal executive offices of Intelligent Bio Solutions Inc.?
The address of the principal executive offices is 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the SEC file number for Intelligent Bio Solutions Inc.?
The SEC file number for Intelligent Bio Solutions Inc. is 001-39825.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-01-29 17:25:33
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- ex99-1_002.jpg (GRAPHIC) — 25KB
- 0001493152-25-004180.txt ( ) — 280KB
- inbs-20250129.xsd (EX-101.SCH) — 3KB
- inbs-20250129_lab.xml (EX-101.LAB) — 33KB
- inbs-20250129_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 29, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer